基于孕妇特征及孕11-13周血清妊娠相关血浆蛋白-A预测小于胎龄儿新生儿的竞争风险模型
前瞻性观察研究纳入60875例单胎妊娠孕妇,在孕11+0至13+6周行常规超声检查,随机分为训练集和测试集,用贝叶斯定理结合PAPP-A似然模型与既往先验模型构建竞争风险模型,内部验证显示该模型预测小于胎龄儿新生儿的性能等于或优于逻辑回归模型及NICE指南方法。
要点
- PAPP-A与出生体重Z评分及分娩孕周呈连续关联,遵循折叠平面回归。
- 新模型在测试集中校准良好,在不同孕周及出生体重百分位间表现一致。
- 按NICE标准约30%假阳性率下,新模型预测<10th百分位SGA的检出率显著高于NICE指南。
核心结论
- 使用贝叶斯定理将PAPP-A测量数据与孕妇特征结合,可改善SGA预测,且在新竞争风险模型框架下性能优于逻辑回归或NICE指南。
研究设计与样本
- 前瞻性观察研究,纳入60875例单胎妊娠孕妇,于孕11+0至13+6周行常规超声检查。
- 数据集随机分为训练集和测试集,训练集用于开发PAPP-A似然模型,测试集用于内部验证。
- 采用贝叶斯定理将既往开发的先验模型(分娩孕周与出生体重Z评分的联合高斯分布)与PAPP-A似然结合,获得后验分布。
- 参考标准为不同出生体重百分位及孕周定义的SGA,对照方法为NICE风险评分系统及逻辑回归模型。
诊断标准与关键数值
- PAPP-A与出生体重Z评分及分娩孕周呈连续关联,遵循折叠平面回归。
- 测试集中,按NICE标准约30%假阳性率时,新模型预测出生体重<10th百分位且分娩<42、<37、<34、<30周的SGA检出率分别为62.7%、66.5%、68.1%、75.3%。
- 对应NICE指南的检出率分别为46.7%、55.0%、55.9%、52.8%,新模型显著更高。
临床应用与阅片要点
- 新模型可基于孕妇特征及孕11-13周PAPP-A测量计算SGA风险,按不同出生体重百分位及孕周定义输出风险。
- 新模型在测试集中校准良好,在不同孕周及出生体重百分位间表现一致。
- 新模型预测性能等于或优于多种逻辑回归模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a continuous likelihood model for pregnancy-associated plasma protein-A (PAPP-A), in the context of a new competing-risks model for prediction of a small-for-gestational-age (SGA) neonate, and to compare the predictive performance of the new model for SGA to that of previous methods.
METHODS: This was a prospective observational study of 60 875 women with singleton pregnancy undergoing routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation. The dataset was divided randomly into a training dataset and a test dataset. The training dataset was used for PAPP-A likelihood model development. We used Bayes' theorem to combine the previously developed prior model for the joint Gaussian distribution of gestational age (GA) at delivery and birth-weight Z-score with the PAPP-A likelihood to obtain a posterior distribution. This patient-specific posterior joint Gaussian distribution of GA at delivery and birth-weight Z-score allows risk calculation for SGA defined in terms of different birth-weight percentiles and GA. The new model was validated internally in the test dataset and we compared its predictive performance to that of the risk-scoring system of the UK National Institute for Health and Care Excellence (NICE) and that of logistic regression models for different SGA definitions.
RESULTS: PAPP-A has a continuous association with both birth-weight Z-score and GA at delivery according to a folded-plane regression. The new model, with the addition of PAPP-A, was equal or superior to several logistic regression models. The new model performed well in terms of risk calibration and consistency across different GAs and birth-weight percentiles. In the test dataset, at a false-positive rate of about 30% using the criteria defined by NICE, the new model predicted 62.7%, 66.5%, 68.1% and 75.3% of cases of a SGA neonate with birth weight < 10th percentile delivered at < 42, < 37, < 34 and < 30 weeks' gestation, respectively, which were significantly higher than the respective values of 46.7%, 55.0%, 55.9% and 52.8% achieved by application of the NICE guidelines.
CONCLUSIONS: Using Bayes' theorem to combine PAPP-A measurement data with maternal characteristics improves the prediction of SGA and performs better than logistic regression or NICE guidelines, in the context of a new competing-risks model for the joint distribution of birth-weight Z-score and GA at delivery. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Papastefanou I, Wright D, Syngelaki A, et al. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics and serum pregnancy-associated plasma protein-A at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2020. PMID: 32770776. doi:10.1002/uog.22175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。